The CYP11B2 gene helps make aldosterone, a hormone that tells the kidneys how much salt and water to keep so blood pressure stays in a healthy range. In medicine, this gene is important because it helps regulate the final step of aldosterone production in the adrenal glands, which sit above the kidneys. If the gene does not work properly, the body may lose too much salt and water, leading to dehydration, low blood pressure, and high potassium levels. Pathogenic variants can cause a rare inherited condition called aldosterone synthase deficiency.
What is a gene?
A gene is a stretch of DNA that holds instructions cells use to make molecules or direct processes in the body. Some genes carry the directions for building proteins, which do much of the work inside cells. Other genes mostly help regulate when certain processes happen, where they occur, and how active they are. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. For a closer look at this topic, you can learn more in the LearnHub.
Overview
CYP11B2Gene function
What if the gene works
The CYP11B2 gene helps your adrenal glands make aldosterone, a hormone that balances salt and water. This supports healthy blood pressure and potassium levels.
Risk
What if the gene does not work
Variants in the CYP11B2 gene can reduce aldosterone production, which may cause salt loss, dehydration, poor feeding, and high potassium, often starting in infancy. Milder variants may cause later or less pronounced symptoms, while more severe variants can present earlier.
Treatment
What does that mean for your treatment
Pathogenic variants in the CYP11B2 gene can make mineralocorticoid replacement central to care, most often with fludrocortisone. In infants and children, extra salt may also be needed, especially during illness or hot weather. Treatment is adjusted to symptoms, growth, blood pressure, and blood potassium levels.
Conditions associated with CYP11B2
Gene function
What if the gene works
Keeping the right balance of salt, water, and potassium depends in part on the CYP11B2 gene. In the adrenal glands, it helps make aldosterone, a hormone that guides how the kidneys manage these minerals and fluids. Understanding how the CYP11B2 gene affects aldosterone helps explain its role in everyday blood pressure control.
In the adrenal glands, the CYP11B2 gene helps cells complete the last steps of making aldosterone. This gives your body a steady way to produce a hormone used every day for fluid and mineral balance.
Aldosterone made with help from the CYP11B2 gene tells the kidneys how much sodium to keep. This supports the right amount of water in the body, since water follows sodium.
The same hormone helps the kidneys release extra potassium into urine. This helps keep potassium in a healthy range, which supports muscle and nerve activity.
By helping make aldosterone, the CYP11B2 gene supports normal blood volume and day to day blood pressure balance. This is part of how your body adjusts after changes in salt intake or fluid loss from sweating.
What is a variant?
A genetic variant is a slight difference in the DNA sequence within a gene. Variants are common and form part of normal human diversity, such as differences in appearance, metabolism, or the body’s response to environmental influences. Many have no noticeable effect at all and simply reflect naturally occurring genetic variation. In some situations, though, a variant can more strongly change how a gene functions and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the CYP11B2 gene can alter the shape, stability, or activity of aldosterone synthase, the enzyme that completes aldosterone production. This is how CYP11B2 gene variants affect aldosterone production at the cellular level. Milder variants may leave some enzyme activity, while more severe variants can greatly reduce or stop it. When both gene copies are strongly affected, symptoms often begin earlier and may be more noticeable.
How variants are linked to conditions
Rare pathogenic variants in the CYP11B2 gene cause aldosterone synthase deficiency, so a confirmed CYP11B2 gene variant linked to aldosterone synthase deficiency can establish that diagnosis. This condition often appears in infancy and may lead to poor feeding, vomiting, dehydration, low sodium, and high potassium. Some common CYP11B2 gene changes have also been studied in relation to blood pressure and primary aldosteronism risk, but these links are not strong enough to diagnose those conditions on their own.
A variant is not necessarily a diagnosis
Genetic variants are common across the general population and are a normal part of human biology. Most do not directly affect health and simply contribute to natural human diversity. For many genes, having a variant associated with a condition points to a possible link rather than a confirmed diagnosis, particularly when more than one gene and environmental influences play a role. In some situations, though, one well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that clearly increase or reduce health risk related to CYP11B2 itself. Some changes in this gene may affect tendencies around aldosterone, salt balance, and blood pressure, but overall risk is also shaped by many other genes, salt intake, kidney and heart health, and some medicines.
Inheritance of CYP11B2 variants
CYP11B2-related aldosterone synthase deficiency is inherited in an autosomal recessive pattern. This means a child usually inherits one CYP11B2 variant from each parent, and both parents are typically healthy carriers. When both parents carry a variant in the CYP11B2 gene, each pregnancy has a 25% chance of being affected, a 50% chance of producing a carrier child, and a 25% chance of producing a child without the family variants. This is the main answer to how CYP11B2 variants are inherited in families.
What does my CYP11B2 result mean for my family?
For CYP11B2, family implications are most often discussed in relation to a rare salt-balance condition that usually runs in families in a recessive way. This means parents are often healthy carriers, brothers and sisters may also be affected or be carriers, and other close relatives could carry the same gene change without knowing it. Family testing can help clarify who else in the family may have the same result.
Genetic information
Genetic testing
How you find out about variants
A blood sample or cheek swab can be used for CYP11B2 genetic testing, where a lab reads the DNA sequence of the CYP11B2 gene to look for variants. Results may show no relevant variant, a known harmful variant, or a variant of uncertain significance, which means its health effect is not yet clear.
When should I consider getting a genetic test?
Genetic testing for the CYP11B2 gene may be worth considering when a baby or child has severe salt loss, dehydration, poor feeding, or high potassium without another clear cause, especially if there is a family history of the same problem. It can help confirm a rare inherited condition that affects aldosterone, the hormone that helps balance salt and fluids.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but what it can tell you varies based on the condition and the kind of variant involved. Many factors, including lifestyle, environment, age, and medical history, influence how the body functions over time. For some conditions, especially those shaped by many genes, genetic information offers context rather than certainty and is most helpful when viewed alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Two people can take the same treatment at the same dose, yet one may get better symptom relief while the other may notice less benefit or more side effects. This happens in part because inherited differences can change how the body breaks down, transports, or responds to a drug. These differences are common and are one reason medication response is not exactly the same for everyone.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in genes can affect the way a person responds to medicines. It studies gene-drug patterns to help explain why the same treatment may work differently in different people. For many medicines, genes influence either how strongly a drug works or how the body processes it. This understanding can support treatment choices that are more informed and more individualized. More detailed information on this topic is available in the LearnHub.
Drugs influenced by the CYP11B2 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice or dose, so general questions about medicines, side effects, blood pressure, or hormone-related symptoms are best discussed with your doctor. CYP11B2 has been studied in research on blood pressure medicines and aldosterone-related treatment response, but these findings are not established enough to direct routine care.
History
CYP11B2 entered medical genetics through research on aldosterone, a hormone that became a major focus in blood pressure and adrenal studies during the 20th century. Initially understood only through hormone measurements, later recognized as tied to a specific gene, CYP11B2 was identified as closely related to the CYP11B1 gene, which helped explain why the two were long difficult to separate in research. From these first observations, research expanded steadily and linked changes in the CYP11B2 gene to rare inherited conditions affecting aldosterone production. Its history is also important in hypertension research, where it helped connect adrenal hormone pathways with inherited differences in blood pressure. Over time, descriptions became more precise as genetic testing improved and could distinguish CYP11B2 more reliably.